Correlation Between Mydecine Innovations and Lobe Sciences

Can any of the company-specific risk be diversified away by investing in both Mydecine Innovations and Lobe Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mydecine Innovations and Lobe Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mydecine Innovations Group and Lobe Sciences, you can compare the effects of market volatilities on Mydecine Innovations and Lobe Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mydecine Innovations with a short position of Lobe Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mydecine Innovations and Lobe Sciences.

Diversification Opportunities for Mydecine Innovations and Lobe Sciences

0.11

Correlation Coefficient

Mydecine Innovations  Lobe Sciences

Average diversification

The 3 months correlation between Mydecine and Lobe is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Mydecine Innovations Group and Lobe Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lobe Sciences and Mydecine Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mydecine Innovations Group are associated (or correlated) with Lobe Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lobe Sciences has no effect on the direction of Mydecine Innovations i.e., Mydecine Innovations and Lobe Sciences go up and down completely randomly.

Pair Corralation between Mydecine Innovations and Lobe Sciences

Assuming the 90 days horizon Mydecine Innovations is expected to generate 6.28 times less return on investment than Lobe Sciences. But when comparing it to its historical volatility, Mydecine Innovations Group is 6.0 times less risky than Lobe Sciences. It trades about 0.19 of its potential returns per unit of risk. Lobe Sciences is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  0.14  in Lobe Sciences on September 19, 2024 and sell it today you would lose (0.02) from holding Lobe Sciences or give up 14.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mydecine Innovations Group  vs.  Lobe Sciences

Mydecine Innovations

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Lobe Sciences

Risk-Adjusted Performance

22 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Lobe Sciences are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Lobe Sciences reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mydecine Innovations and Lobe Sciences

The main advantage of trading using opposite Mydecine Innovations and Lobe Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mydecine Innovations position performs unexpectedly, Lobe Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lobe Sciences will offset losses from the drop in Lobe Sciences' long position.

The idea behind Mydecine Innovations Group and Lobe Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .